Edition:
United States

Rosetta Genomics Ltd (ROSG.OQ)

ROSG.OQ on NASDAQ Stock Exchange Capital Market

0.33USD
4:00pm EDT
Change (% chg)

$-0.01 (-2.94%)
Prev Close
$0.34
Open
$0.36
Day's High
$0.36
Day's Low
$0.33
Volume
4,258
Avg. Vol
35,896
52-wk High
$2.82
52-wk Low
$0.26

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.87 -0.449
Mar '17 0.74 -0.739
FY 2016 Dec '16 2.02 -2.727
Sep '16 2.20 -2.281
Jun '16 0.40 -1.875
Mar '16 2.60 -2.346
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.44 32.31
P/E High - Last 5 Yrs. -- 280.78 46.12
P/E Low - Last 5 Yrs. -- 95.19 24.71
Beta 0.49 0.75 0.79
Price to Sales (TTM) 0.36 144.18 7.14
Price to Book (MRQ) 0.82 18.80 4.88
Price to Tangible Book (MRQ) 1.89 23.34 6.49
Price to Cash Flow (TTM) -- 117.05 24.37
% Owned Institutions 14.49 11.29 2.32

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.58
Dividend Yield - 5 Year Avg -- 0.20 0.78
Dividend 5 Year Growth Rate -- 1.96 4.08
Payout Ratio(TTM) -- 9.23 21.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 115.35 103.37 9.18
Sales (TTM) vs TTM 1 Yr. Ago -35.23 79.40 11.01
Sales - 5 Yr. Growth Rate 145.76 33.48 8.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 76.08 -66.76 23.62
EPS (TTM) vs TTM 1 Yr. Ago 47.52 -- --
EPS - 5 Yr. Growth Rate -- 46.41 10.39
Capital Spending - 5 Yr. Growth Rate 82.55 44.90 10.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.70 2.52
Current Ratio (MRQ) 2.09 5.99 3.58
LT Debt to Equity (MRQ) 3.37 23.56 11.61
Total Debt to Equity (MRQ) 8.37 26.01 14.31
Interest Coverage (TTM) -8.42 -183.16 30.88

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 16.06 31.78 54.20
Gross Margin - 5 Yr. Avg. 17.74 55.29 52.34
EBITD Margin (TTM) -219.63 -- --
EBITD - 5 Yr. Avg -333.85 -149.45 15.90
Operating Margin (TTM) -219.63 -587.01 3.62
Operating Margin - 5 Yr. Avg. -346.03 -161.52 11.17
Pre-Tax Margin (TTM) -201.70 -560.40 4.27
Pre-Tax Margin - 5 Yr. Avg. -370.31 -168.41 11.48
Net Profit Margin (TTM) -200.91 -548.74 0.90
Net Profit Margin - 5 Yr. Avg. -370.31 -168.67 7.81
Effective Tax Rate (TTM) -- -0.45 31.67
Effective Tax Rate - 5 Yr. Avg. -- 18.02 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 67,756 23,441,753 786,924,448
Net Income/Employee (TTM) -136,128 684,681 92,306,248
Receivable Turnover (TTM) 3.03 6.13 5.48
Inventory Turnover (TTM) -- 2.39 3.46
Asset Turnover (TTM) 0.53 0.40 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -106.42 -0.78 10.35
Return on Assets - 5 Yr. Avg. -68.47 0.53 11.38
Return on Investment (TTM) -144.23 -0.73 12.97
Return on Investment - 5 Yr. Avg. -76.51 3.99 14.74
Return on Equity (TTM) -170.31 -2.77 14.84
Return on Equity - 5 Yr. Avg. -78.87 -0.21 16.08
  1 Year 3 Year 5 Year
Sales % 11.68 183.56 145.76
EPS (TTM) % 32.47 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Rosetta Genomics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.49%
# of Holders: 13
Total Shares Held: 859,495
3 Mo. Net Change: 351,372
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.